Semax is a synthetic research peptide composed of seven amino acids and derived from a fragment of adrenocorticotropic hormone (ACTH). Unlike the parent hormone, Semax has been studied primarily for its neurological signaling properties and has become an area of laboratory investigation involving neurotrophic pathways, neuronal signaling, cognitive biology, and cellular responses within the nervous system.

Semax research has explored its relationship with neurotrophic factors and signaling pathways associated with neuronal activity and plasticity. Researchers have investigated its interaction with biological processes involving brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), and other mechanisms involved in neuronal communication and adaptation.

Another significant area of Semax research involves neurotransmitter activity and cellular responses to neurological stress. Laboratory studies have examined its relationship with dopaminergic and serotonergic signaling, oxidative processes, gene expression, and mechanisms associated with neuronal function.

Semax has a molecular weight of approximately 813.9 g/mol and can be synthetically produced for controlled research applications. This 10mg formulation is supplied in a nasal research format for laboratory investigation involving neurotrophic signaling, neuronal biology, neurotransmitter activity, and related cellular pathways.